Maryland Venture Fund

Maryland Venture Fund, established in 1994 and based in Columbia, Maryland, is an early-stage venture capital firm with a focus on nurturing innovative companies within the state. With a capital base of $110 million, the Fund engages in both direct investments in technology and life sciences, as well as indirect investments in venture capital funds. It typically invests between $0.1 million and $1 million in companies that generate revenues up to $1 million, primarily targeting businesses with fewer than 50 employees that have been operational for no more than five years. The Fund specializes in sectors such as healthcare technology, cybersecurity, and information technology. Investments are structured as equity or convertible debt, and the firm seeks to support companies certified as qualified Maryland cybersecurity entities by the state’s Department of Business and Economic Development.

Bill Collier

Director

84 past transactions

Attila

Series A in 2020
Attila Security, Inc. specializes in developing security solutions for networks and data access across virtual and cloud applications. Founded in 2018 and based in Columbia, Maryland, the company offers a range of products including the GoSilent Cube, a portable enterprise-grade firewall and virtual private network, GoSilent Global, which provides secure data access through dual Internet protocol obfuscation, and GoSilent Server, designed for accessing data center applications and cloud services. Attila's technology aims to protect various devices, such as servers, desktops, laptops, smartphones, and IoT devices, from cyber threats, addressing the significant economic impact of cybercrime. The company serves both government entities and enterprises, ensuring that sensitive data remains secure as it is accessed by employees across different platforms.

Xometry

Series D in 2019
Xometry offers an AI-enabled marketplace for on-demand manufacturing services, connecting buyers with manufacturers for efficient sourcing of parts and assemblies. Services include CNC machining, 3D printing, injection molding, urethane casting, die casting, and more.

scaleMatters

Seed Round in 2019
scaleMatters, Inc. is a specialized provider of data-driven marketing and sales automation solutions, established in 2018 and based in Montgomery County, Maryland. The company focuses on enhancing the Go-to-Market (GTM) performance of private equity-backed organizations by offering comprehensive analytics-as-a-service. Its platform delivers precise visibility into the GTM engine by employing a sophisticated data model within the sales and marketing technology stack. This approach ensures accurate data capture, cleanses historical information, and maintains data integrity, thereby equipping businesses with the revenue intelligence necessary for informed decision-making. Clients, including portfolio companies of prominent private equity firms, rely on scaleMatters to improve their operational efficiency, achieve predictable outcomes, and streamline reporting processes.

Racktop Systems

Series A in 2019
RackTop Systems, Inc. develops innovative data center solutions with a focus on data security and storage performance. The company's flagship product, BrickStor, is available in several versions: BrickStor Iron, which serves as an enterprise storage platform; BrickStor Titanium, tailored for private cloud environments; BrickStor zFLASH, which offers flash storage with high performance; and BrickStor SP, a software-defined primary data solution that implements a data-centric Zero Trust model to protect against cyber threats such as ransomware. Other offerings include an object storage platform called OSP, enterprise networking solutions through FlexBox, and virtual desktop infrastructure support with vBox. Additionally, RackTop provides MyRacktop, a secure multi-tenant cloud, and an enterprise backup and recovery appliance. The company also delivers consulting services in data storage optimization and information security to various sectors, including banking, education, and government. Founded in 2010 and headquartered in Fulton, Maryland, RackTop Systems has gained recognition for its innovative approach to cybersecurity and data management.

Curbio

Seed Round in 2018
Curbio Inc. is a home renovation service provider based in Potomac, Maryland. Founded in 2017, the company specializes in pre-sale home renovations designed to assist real estate agents and homeowners in preparing properties for sale. Curbio leverages technology to enhance the home improvement process, offering features such as virtual estimates and automated communication, which streamline project management. By partnering with real estate agents, Curbio delivers a hassle-free experience aimed at ensuring homes are market-ready and sold quickly. The company employs a unique pay-at-closing model, allowing homeowners to manage costs effectively while preparing their homes for listing. Originally established as MaxSalePrice, Inc., Curbio rebranded in October 2018 to better reflect its focus on the real estate market.

Threater

Series A in 2018
Threater delivers a comprehensive cybersecurity platform focused on active network defense. The system automates the discovery, enforcement, and analysis of cyber threats at scale, enabling organizations to detect and neutralize risks proactively and automatically. Its patented technology blocks all known threats, allowing the rest of the security stack to operate more efficiently. By integrating threat detection, enforcement, and response into a single solution, Threater helps enterprises safeguard their networks and data against evolving cyber threats.

Neuraly

Series A in 2018
Neuraly, Inc. is a clinical-stage biotechnology company based in Germantown, Maryland, focused on developing innovative treatments for neurodegenerative diseases, including Parkinson's and Alzheimer's diseases. Founded in 2016, the company emerged from research led by prominent neuroscientists and has secured exclusive licenses for key patents related to its drug candidates. Neuraly is advancing several compounds, notably NLY01, a neuroprotective agent designed to inhibit pathological microglial activation, and NLY02 and NLY03, which are blood-brain barrier-penetrating kinase inhibitors. The company's approach aims to address the underlying mechanisms of neurodegeneration by targeting glial cell activity and preventing neuronal cell death, with the ultimate goal of improving the quality of life for patients affected by these debilitating conditions.

Xometry

Series C in 2018
Xometry offers an AI-enabled marketplace for on-demand manufacturing services, connecting buyers with manufacturers for efficient sourcing of parts and assemblies. Services include CNC machining, 3D printing, injection molding, urethane casting, die casting, and more.

QxBranch

Seed Round in 2018
QxBranch, Inc. is a technology company that specializes in developing analytics solutions as a service, focusing on both quantum and classical computing. Founded in 2014 and headquartered in Washington, D.C., with additional offices in London and Adelaide, the company provides advanced algorithms and software aimed at predictive analytics, forecasting, and optimization. QxBranch serves a diverse range of industries, including finance, insurance, aerospace, pharmaceuticals, media, and energy, catering to high-profile clients such as Fortune 100 companies, investment banks, and defense contractors. In addition to its software offerings, QxBranch also provides technical consulting and analysis services to help organizations tackle complex analytics challenges. As of 2019, QxBranch operates as a subsidiary of Rigetti & Co, Inc.

Blackpoint Cyber

Venture Round in 2018
Blackpoint Holdings, LLC, founded in 2014 and based in Ellicott City, Maryland, specializes in cybersecurity products and services designed to safeguard organizational infrastructure and operations. The company offers a range of solutions, including Blackpoint RISK, a cyber liability insurance product that protects against incidents such as cyber-crime and ransomware. Its flagship platform, SNAP-Defense, provides advanced threat detection and response capabilities, allowing organizations to identify and neutralize threats at their earliest stages. The platform's real-time monitoring delivers alerts directly to the user interface, enabling quick action to contain affected devices. Additionally, SNAP-Defense supports deep data analysis, enhancing the user experience with its intuitive design. Blackpoint's comprehensive approach to cybersecurity enables clients to fortify their defenses and effectively manage potential threats.

Homecare.com

Venture Round in 2018
Homecare.com provides expert information, practical action steps, guides, resources, and personalized plans to help caregivers make sound decisions and successfully navigate the complex world of eldercare. It offers a whole new world for caregivers: one where they can do the very best for their parents, older family members, or friends who need care. Its platform helps the families and caregivers to connect with each other, enabling families and health care providers to interview, hire, and manage fully credentialed, insured, and bonded caregivers. Homecare.com was founded in 2014 and is based in Mclean, Virginia.

Personal Genome Diagnostics

Series B in 2018
Personal Genome Diagnostics, Inc. is a biotechnology company focused on patient-specific analyses of cancer genomes. Established in 2010 and headquartered in Baltimore, Maryland, the company has pioneered technologies for non-invasive "liquid biopsy" approaches, allowing for the detection of tumor-specific alterations in circulating cell-free DNA. Its offerings include the METDetect Assay for identifying MET gene amplifications, LungSelect for detecting actionable genetic alterations in non-small cell lung cancer patients, and PGDx elio plasma resolve, which analyzes various genetic mutations from plasma samples. Additionally, Personal Genome Diagnostics provides RNAcomplete, enabling researchers to extract both RNA and genomic DNA from a single tissue sample, and CancerXOME, which captures and analyzes coding regions of genes. The company collaborates with institutions like Mayo Clinic and partners with KingMed Diagnostics to enhance its research and diagnostic capabilities, thereby empowering oncologists and researchers with crucial genomic insights to combat cancer.

D&D Pharmatech

Series A in 2018
D&D Pharmatech Co., Ltd., established in 2014 and headquartered in Seongnam, South Korea, is a clinical-stage global biotech company specializing in developing innovative medicines. It focuses on various therapeutic areas, including neurodegenerative diseases, molecular imaging and radiotherapy, fibrotic diseases, and metabolic diseases. The company operates through disease-specific subsidiary companies guided by top-tier medical research faculty, aiming to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech's product pipeline is supported by its team of experts in bio-new drug research and development, manufacturing quality control, clinical development, and technology transfer. Additionally, it develops positron emission tomography (PET) imaging biomarkers through Precision Molecular Inc., a wholly-owned subsidiary, and conducts single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. The company employs technologies such as PEGylation to extend drug administration periods.

BrainScope Company

Venture Round in 2017
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.

Aledade

Series B in 2017
Aledade is a health technology and services platform that partners with independent primary care physicians to form and operate Accountable Care Organizations in the United States. It provides data analytics, guided workflows, regulatory and contracting support, payer relationships, and local on-the-ground expertise to help practices transform operations, optimize care delivery, and align incentives around value-based care. The platform integrates care data across the continuum, offers practice management tools, and supports governance and policy guidance to enable autonomous physician groups—from small practices to multispecialty networks and community health centers—to improve patient outcomes while reducing overall costs. Headquartered in Bethesda, Maryland, the company was founded in 2014.

Fugue

Series D in 2017
Fugue develops an operating system for managing cloud-based workloads, ensuring continuous compliance with enterprise security policies. Its solution identifies and remediates cloud infrastructure security risks and compliance violations, preventing data breaches. Fugue automates compliance audits using out-of-the-box frameworks such as HIPAA, GDPR, CIS Benchmark, and NIST 800-53, supporting custom policies. It integrates with CI/CD pipelines to enforce compliance and prevent unauthorized changes.

Optoro

Series D in 2016
Optoro, Inc. is a provider of a reverse logistics platform that specializes in managing distressed inventory for retailers, manufacturers, and third-party providers. Founded in 2004 and based in Washington, D.C., with an additional location in Mt. Juliet, Tennessee, the company offers asset recovery solutions that include direct-to-consumer remarketing of customer returns, overstock, discontinued products, and refurbished items through various online channels. Optoro's software-as-a-service (SaaS) platform features a returns management system that manages the entire returns lifecycle, from initiation to resale, integrating customer-facing channels with back-end operational systems. The company also provides inventory management services, which encompass warehousing, fulfillment, inspection, testing, and eco-friendly disposal, as well as asset maximization services that utilize data analytics for multi-channel remarketing and reporting. With a focus on enhancing recovery and minimizing environmental waste, Optoro serves clients both in the United States and internationally.

Healthcare Interactive

Series A in 2016
Healthcare Interactive, Inc. specializes in health planning solutions aimed at enhancing the administration and delivery of healthcare. Founded in 2006 and headquartered in Glenwood, Maryland, the company offers a cloud-based platform called Healthspace, designed to manage various components of benefits plans. This platform facilitates the integration of data, risk management, member engagement, incentive alignment, and performance measurement. Healthcare Interactive provides a range of services, including automated benefits plan management, workplace well-being solutions like health risk assessments and clinical health coaching, incentive management, direct contract primary care, and compliance solutions for ACA reporting. The company's focus is on enabling client-partners to utilize their data effectively to identify health risks and cost drivers, develop targeted programs, and implement administrative tools that enhance health outcomes within communities. Healthcare Interactive operates as a subsidiary of WellNet Healthcare Administrators, Inc.

Perceptive Navigation

Seed Round in 2015
Perceptive Navigation LLC is a pre-clinical stage medical device company based in Baltimore, Maryland, focused on developing innovative interventional medical devices for the image-guided surgery market. The company is known for its flagship product, Vu-Path, an intracorporeal ultrasound device that integrates front-viewing ultrasound imaging with a working portal. This unique combination allows for the precise introduction of needles, biopsy instruments, guide wires, and therapeutic agents into the body. Vu-Path aims to enhance the safety and efficacy of minimally invasive procedures across multiple medical disciplines, including radiology, cardiology, interventional oncology, and urology. Traditional imaging techniques often pose challenges such as high costs, complexity, and risks associated with patient safety. Vu-Path addresses these issues by facilitating quicker and safer access to internal organs while reducing the need for extensive training and equipment. With its patented technology, Perceptive Navigation seeks to transform the landscape of interventional medicine, improving outcomes for both patients and healthcare providers.

Alio

Seed Round in 2015
Founded in 2012, Alio specializes in remote patient monitoring technology. Its wearable devices measure vital signs and blood parameters for dialysis patients, providing real-time data to physicians for informed decision-making.

Tales2Go

Series A in 2015
Tales2Go Inc., based in Bethesda, Maryland, is an audiobook subscription service that provides educators, parents, and students with on-demand access to thousands of titles from leading publishers and storytellers. Founded in 2009, the company offers a mobile and desktop streaming solution designed to enhance literacy through audiobooks, which foster listening comprehension, fluency, and vocabulary development. By integrating audiobooks into educational settings, Tales2Go supports the Common Core Standards that emphasize the importance of listening skills in early literacy. The service is particularly beneficial in classrooms equipped with laptops and mobile devices, serving as an innovative upgrade for school media centers to engage students and improve reading outcomes.

Blue Pillar

Venture Round in 2015
Founded in 2006, Blue Pillar develops software solutions for strengthening critical infrastructure against power outages. Its platform, Aurora, creates a digital energy IoT network for connecting, controlling, and data acquisition of facility mechanical and electrical equipment. Avise Insite provides real-time equipment diagrams for single-site management, while Avise Foresite supports centralized management across multi-facility organizations. Serving industries such as healthcare, government, and data centers, Blue Pillar's solutions offer power-related situational awareness, emergency management, operational efficiencies, and energy savings.

GrayBug

Series A in 2015
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for diseases affecting the retina and optic nerve. Founded in 2011 and based in Redwood City, California, the company focuses on chronic vision-threatening conditions. Its lead product candidate, GB-102, is an intravitreal injection undergoing clinical trials for wet age-related macular degeneration and diabetic macular edema. Additionally, Graybug is advancing GB-103, a once-a-year formulation aimed at treating diabetic retinopathy, and GB-401, a depot formulation targeting primary open-angle glaucoma. The company utilizes proprietary micro- and nanoparticle controlled release technologies to enhance drug delivery in ocular tissues, thereby improving patient compliance and clinical outcomes. Graybug Vision was previously known as Graybug LLC before its rebranding in 2016.

Mobile System 7

Convertible Note in 2015
Mobile System 7 is an enterprise security company founded by former Intelligence Community professionals, specializing in the protection of enterprise data from unauthorized access and cyber threats. The company's flagship product, Interlock, distinguishes itself from traditional security solutions by focusing not merely on securing endpoints, but on safeguarding access to critical data and services. By leveraging advanced analytics and real-time access controls, Interlock effectively monitors and protects valuable enterprise information. In addition to Interlock, Mobile System 7 also offers a data-driven Sentry platform designed to secure, deploy, and manage mobile devices within organizations, further enhancing its comprehensive approach to enterprise security.

Citelighter

Seed Round in 2015
Citelighter is a web-based academic research tool designed to streamline the research and paper writing process. It enables users to efficiently find and capture unique facts from online sources, while also automating the citation generation and bibliography creation. The platform offers features that assist in developing project outlines and aggregating personalized content, enhancing the overall quality of written work. Citelighter's fact-recommendation system indexes captured information, providing users with relevant suggestions to improve their research efforts. By leveraging a community of students, Citelighter enhances its database of valuable content, allowing users to conduct research more effectively.

Motionsoft

Series B in 2014
Motionsoft, Inc. is a developer of gym management software solutions, offering a range of products tailored for fitness clubs, corporate wellness facilities, hospital wellness centers, and university recreation centers. The company’s flagship offerings include MoSo Club, a cloud-based platform for payment processing, and MoSo Enterprise, an enterprise management suite designed to help users analyze data for informed decision-making. Motionsoft provides various software modules such as Front Desk Check-In for member engagement, Kids’ Club for childcare management, smart locker management, access control solutions, and scheduling software for training services. Additionally, its offerings include membership management, mobile applications, and point of sale systems, enabling clients to streamline operations and enhance member acquisition and retention. Founded in 2004 and based in Rockville, Maryland, Motionsoft was previously known as KI Software, Inc. and became a subsidiary of DAXKO LLC in 2020.

SalesWarp

Venture Round in 2014
SalesWarp is a cloud-based software provider that empowers retailers to manage their e-commerce business efficiently. It offers an integrated platform for inventory management, order processing, and fulfillment across multiple channels, including online marketplaces like Amazon and eBay, and e-commerce platforms such as Magento and Shopify. SalesWarp's solutions streamline product listing, order management, shipping, and supplier communication, enabling retailers to deliver a seamless omni-channel shopping experience.

Three Ring

Series A in 2014
Three Ring, Inc. is an educational technology company that operates an online platform designed to help schools and districts capture, organize, and share student learning information with administrators, parents, and students. Founded in 2011 and based in Baltimore, Maryland, the company offers a software solution that supports one-to-one programs and Bring Your Own Device (BYOD) initiatives, facilitating project-based learning, performance tasks, flipped classrooms, and digital portfolios. Three Ring's platform allows users to upload and manage multimedia evidence of student growth, enabling teachers and students to securely gather and share authentic learning experiences. The company also provides a mobile application compatible with Android and iOS, which allows users to capture photos, record audio and video, and upload digital files from various devices. Three Ring's services are utilized by educational institutions across the United States and internationally.

Harpoon Medical

Series A in 2014
Harpoon Medical, Inc. is a medical device company based in Baltimore, Maryland, focused on developing and commercializing innovative transcatheter devices for patients with mitral valve disease. Founded in 2013, the company has pioneered a minimally invasive, image-guided surgical tool designed for repairing the mitral valve on a beating heart. This technology, developed at the University of Maryland School of Medicine, allows surgeons to perform repairs through a small incision between the ribs, eliminating the need for cardiac arrest or cardiopulmonary bypass. The Harpoon device utilizes a technique that involves inserting neochords to effectively eliminate mitral valve regurgitation. By streamlining the traditional open-heart surgical procedure, which typically lasts 3 to 6 hours, into a more efficient 60-minute operation, Harpoon Medical aims to significantly reduce recovery times, enabling patients to return to their normal activities much sooner. As a subsidiary of Edwards Lifesciences Corporation since 2017, Harpoon Medical continues to work towards transforming the treatment landscape for mitral valve disease.

Fugue

Series B in 2014
Fugue develops an operating system for managing cloud-based workloads, ensuring continuous compliance with enterprise security policies. Its solution identifies and remediates cloud infrastructure security risks and compliance violations, preventing data breaches. Fugue automates compliance audits using out-of-the-box frameworks such as HIPAA, GDPR, CIS Benchmark, and NIST 800-53, supporting custom policies. It integrates with CI/CD pipelines to enforce compliance and prevent unauthorized changes.

Pulse 8

Venture Round in 2014
Reimagining data to help people live independent and healthy lives. We love databases, risk adjustment, algorithms, and finding new ways to use healthcare data. We are a compassionate team of thought leaders and industry experts focused on bringing our clients the best value through our advanced analytical solutions. We strive to enhance our clients’ products and services by providing innovative and transformative knowledge that will increase revenues, contain costs, improve products, and help people live healthier and longer lives. Our values, technology, experiences, and skills create a unique approach to solving many of today’s complex issues in healthcare.

Synapsify

Venture Round in 2014
Synapsify, Inc. is a technology company based in Bethesda, Maryland, founded in 2012. It specializes in developing applications that leverage machine intelligence and natural language processing to semantically read and analyze written content. The company's flagship product, Synapsify Core, is an analytical tool designed to help marketers, researchers, and insight professionals gain deeper understanding from open-ended survey responses, social media posts, and customer reviews. In addition, Synapsify offers the Synapsify Core API, which allows developers to integrate text analytics functionalities into their own applications. The company provides customized reporting solutions tailored to various use cases, including brand development, reputation management, customer experience management, and competitive analysis. Recognized by Forbes as one of the Top 10 Data Startups to Watch, Synapsify has also received accolades for its innovative approach to text analytics.

Triumfant

Venture Round in 2014
Triumfant is a provider of advanced endpoint security software that offers continuous protection against sophisticated malware threats. The company's innovative technology enables users to detect, analyze, and swiftly resolve cyberattacks that evade conventional signature-based defenses. Triumfant's system is designed to stop breaches before they escalate into significant incidents, ensuring that no attacker can extract proprietary information or inflict damage on enterprise systems. It features enhanced detection capabilities, including advanced memory and Mac functionalities, minimizing collateral damage and safeguarding critical assets. In the event of an attack, Triumfant automatically repairs affected machines within minutes without the need for human intervention or system downtime, allowing companies and government agencies to quickly recover and prevent potential losses.

KoolSpan

Venture Round in 2014
Founded in 2003, KoolSpan specializes in secure communication solutions for businesses and consumers. It offers end-to-end encryption for phone calls and messages across various platforms, including Android, iPhone, and BlackBerry. With a focus on data privacy and security, KoolSpan serves customers worldwide from industries such as government, finance, healthcare, and more. Its solutions are FIPS 140-2 validated.

Maxtena

Venture Round in 2014
Founded in 2006, Maxtena specializes in designing and manufacturing advanced satellite antennas and wireless communication systems. The company offers a range of antennas for various applications including Global Navigation Satellite Systems (GNSS), SATCOM, and 4G LTE. Serving industries such as automotive, mobile computing, healthcare, and power management, Maxtena empowers customers with precision and autonomous multi-frequency solutions.

Tales2Go

Venture Round in 2014
Tales2Go Inc., based in Bethesda, Maryland, is an audiobook subscription service that provides educators, parents, and students with on-demand access to thousands of titles from leading publishers and storytellers. Founded in 2009, the company offers a mobile and desktop streaming solution designed to enhance literacy through audiobooks, which foster listening comprehension, fluency, and vocabulary development. By integrating audiobooks into educational settings, Tales2Go supports the Common Core Standards that emphasize the importance of listening skills in early literacy. The service is particularly beneficial in classrooms equipped with laptops and mobile devices, serving as an innovative upgrade for school media centers to engage students and improve reading outcomes.

Salsa Labs

Venture Round in 2014
Salsa Labs, Inc. is a Software-as-a-Service (SaaS) company based in Bethesda, Maryland, that specializes in providing a comprehensive suite of software tools designed for nonprofit organizations. Founded in 2003, Salsa Labs offers an integrated supporter engagement platform that combines fundraising, advocacy, and marketing engagement functionalities. Its software suite includes features for donor management, digital marketing, online fundraising, and peer-to-peer fundraising, enabling nonprofits to effectively engage with their communities and rally support. By unifying online and offline outreach tools, Salsa Labs empowers organizations to develop rich supporter profiles, optimize communication strategies, and enhance fundraising capabilities. The company is committed to improving staff efficiency and deepening relationships between nonprofits and their supporters through its innovative solutions and dedicated customer support.

CytImmune Sciences

Series C in 2014
CytImmune Sciences is a clinical-stage company developing tumor-targeted therapies using its Aurimune nanomedicine platform. This platform carries therapeutic agents directly into tumors, disrupting their defenses and enhancing the effectiveness of other treatments like chemotherapy and immunotherapy.

CellPhire

Debt Financing in 2014
CellPhire is a clinical-stage biotechnology company focused on developing a proprietary method for stabilizing blood components, particularly platelets, in a dry state. This technology aims to extend the shelf life of platelets beyond the current limit of five days, addressing critical shortages that can disrupt treatments for cancer patients and those requiring urgent care in surgical or trauma situations. By creating stabilized platelets, CellPhire seeks to provide a reliable supply of hemostatic agents that can be used in advanced wound care, transfusions, and diagnostic applications. The company’s innovations are particularly relevant in the context of potential national emergencies, such as pandemics or natural disasters, where the fragile supply of platelets could be significantly compromised.

BioDatomics

Seed Round in 2014
BioDatomics, LLC is a bioinformatics company based in Bethesda, Maryland, focused on providing innovative software tools for genomic and biomedical researchers. Founded in 2011, the company specializes in developing solutions that facilitate the analysis of complex biological data, particularly in the omics field. BioDatomics offers BioDT, an open-source next-generation sequencing (NGS) data analysis platform tailored for genome analysis and exome sequencing. The software is designed to enhance research productivity by offering an intuitive interface, enabling real-time collaboration among researchers, and providing rapid analysis turnaround times. Through its tools, BioDatomics aims to accelerate the extraction of valuable insights from genomic data, supporting advancements in life sciences.

CytImmune Sciences

Venture Round in 2014
CytImmune Sciences is a clinical-stage company developing tumor-targeted therapies using its Aurimune nanomedicine platform. This platform carries therapeutic agents directly into tumors, disrupting their defenses and enhancing the effectiveness of other treatments like chemotherapy and immunotherapy.

Mobile System 7

Seed Round in 2014
Mobile System 7 is an enterprise security company founded by former Intelligence Community professionals, specializing in the protection of enterprise data from unauthorized access and cyber threats. The company's flagship product, Interlock, distinguishes itself from traditional security solutions by focusing not merely on securing endpoints, but on safeguarding access to critical data and services. By leveraging advanced analytics and real-time access controls, Interlock effectively monitors and protects valuable enterprise information. In addition to Interlock, Mobile System 7 also offers a data-driven Sentry platform designed to secure, deploy, and manage mobile devices within organizations, further enhancing its comprehensive approach to enterprise security.

Tales2Go

Seed Round in 2014
Tales2Go Inc., based in Bethesda, Maryland, is an audiobook subscription service that provides educators, parents, and students with on-demand access to thousands of titles from leading publishers and storytellers. Founded in 2009, the company offers a mobile and desktop streaming solution designed to enhance literacy through audiobooks, which foster listening comprehension, fluency, and vocabulary development. By integrating audiobooks into educational settings, Tales2Go supports the Common Core Standards that emphasize the importance of listening skills in early literacy. The service is particularly beneficial in classrooms equipped with laptops and mobile devices, serving as an innovative upgrade for school media centers to engage students and improve reading outcomes.

CoFoundersLab

Venture Round in 2014
CoFoundersLab is an online platform designed to facilitate connections among entrepreneurs. It provides a space for individuals to find co-founders, advisors, and team members, as well as to hire freelancers for various business needs. Users can engage in discussions by asking and answering both technical and non-technical questions. The platform also offers a low-fee, no-equity Virtual Accelerator to help entrepreneurs progress their ideas. Additionally, CoFoundersLab features a Learning Center for skill development and hosts in-person match-up events to foster networking opportunities. By leveraging technology and AI algorithms, CoFoundersLab aims to create a supportive environment for entrepreneurial-minded individuals seeking the necessary resources to succeed in their ventures.

Fugue

Series A in 2014
Fugue develops an operating system for managing cloud-based workloads, ensuring continuous compliance with enterprise security policies. Its solution identifies and remediates cloud infrastructure security risks and compliance violations, preventing data breaches. Fugue automates compliance audits using out-of-the-box frameworks such as HIPAA, GDPR, CIS Benchmark, and NIST 800-53, supporting custom policies. It integrates with CI/CD pipelines to enforce compliance and prevent unauthorized changes.

3CLogic

Series B in 2014
3CLogic is a cloud-based contact center solutions provider that enables organizations to manage internal and external communications and customer engagements through interactive voice response and multi-channel automatic call distribution for call routing and a predictive dialer. The platform supports inbound, outbound, and blended interactions across industries such as finance, real estate, insurance, e-commerce, healthcare, and education. It integrates with cloud-based customer relationship management and data platforms to extend CRM capabilities, enabling scalable features like self-service experiences, live and virtual agent interactions, and conversational analytics. 3CLogic offers flexible deployment options, from simple connectors between legacy telephony and cloud CRM to hybrid or full cloud deployments, designed to improve operational efficiency and customer service management through automation, consolidated reporting, and analytics.

BioDatomics

Seed Round in 2014
BioDatomics, LLC is a bioinformatics company based in Bethesda, Maryland, focused on providing innovative software tools for genomic and biomedical researchers. Founded in 2011, the company specializes in developing solutions that facilitate the analysis of complex biological data, particularly in the omics field. BioDatomics offers BioDT, an open-source next-generation sequencing (NGS) data analysis platform tailored for genome analysis and exome sequencing. The software is designed to enhance research productivity by offering an intuitive interface, enabling real-time collaboration among researchers, and providing rapid analysis turnaround times. Through its tools, BioDatomics aims to accelerate the extraction of valuable insights from genomic data, supporting advancements in life sciences.

BrainScope Company

Grant in 2014
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.

CoFoundersLab

Equity Crowdfunding in 2014
CoFoundersLab is an online platform designed to facilitate connections among entrepreneurs. It provides a space for individuals to find co-founders, advisors, and team members, as well as to hire freelancers for various business needs. Users can engage in discussions by asking and answering both technical and non-technical questions. The platform also offers a low-fee, no-equity Virtual Accelerator to help entrepreneurs progress their ideas. Additionally, CoFoundersLab features a Learning Center for skill development and hosts in-person match-up events to foster networking opportunities. By leveraging technology and AI algorithms, CoFoundersLab aims to create a supportive environment for entrepreneurial-minded individuals seeking the necessary resources to succeed in their ventures.

Pulse 8

Series A in 2013
Reimagining data to help people live independent and healthy lives. We love databases, risk adjustment, algorithms, and finding new ways to use healthcare data. We are a compassionate team of thought leaders and industry experts focused on bringing our clients the best value through our advanced analytical solutions. We strive to enhance our clients’ products and services by providing innovative and transformative knowledge that will increase revenues, contain costs, improve products, and help people live healthier and longer lives. Our values, technology, experiences, and skills create a unique approach to solving many of today’s complex issues in healthcare.

SalesWarp

Convertible Note in 2013
SalesWarp is a cloud-based software provider that empowers retailers to manage their e-commerce business efficiently. It offers an integrated platform for inventory management, order processing, and fulfillment across multiple channels, including online marketplaces like Amazon and eBay, and e-commerce platforms such as Magento and Shopify. SalesWarp's solutions streamline product listing, order management, shipping, and supplier communication, enabling retailers to deliver a seamless omni-channel shopping experience.

Plasmonix

Series A in 2013
Plasmonix is a biotechnology company founded in 2009 and located in Baltimore, Maryland. It specializes in Metal Enhanced Fluorescence (MEF) technology, which significantly improves the emission of light signals, allowing for the detection of molecular targets at concentrations as low as several hundred molecules. This advancement facilitates applications in life sciences and diagnostic assays. Additionally, Plasmonix develops a cell lysis device that employs microwave energy to break open bacterial and cellular contents, enabling the analysis of their molecular components and genetic profiles. Through its innovative technologies, Plasmonix aims to enhance detection capabilities in various scientific fields.

BrainScope Company

Convertible Note in 2013
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.

GrayBug

Series A in 2013
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for diseases affecting the retina and optic nerve. Founded in 2011 and based in Redwood City, California, the company focuses on chronic vision-threatening conditions. Its lead product candidate, GB-102, is an intravitreal injection undergoing clinical trials for wet age-related macular degeneration and diabetic macular edema. Additionally, Graybug is advancing GB-103, a once-a-year formulation aimed at treating diabetic retinopathy, and GB-401, a depot formulation targeting primary open-angle glaucoma. The company utilizes proprietary micro- and nanoparticle controlled release technologies to enhance drug delivery in ocular tissues, thereby improving patient compliance and clinical outcomes. Graybug Vision was previously known as Graybug LLC before its rebranding in 2016.

Fugue

Convertible Note in 2013
Fugue develops an operating system for managing cloud-based workloads, ensuring continuous compliance with enterprise security policies. Its solution identifies and remediates cloud infrastructure security risks and compliance violations, preventing data breaches. Fugue automates compliance audits using out-of-the-box frameworks such as HIPAA, GDPR, CIS Benchmark, and NIST 800-53, supporting custom policies. It integrates with CI/CD pipelines to enforce compliance and prevent unauthorized changes.

Zeuss

Convertible Note in 2013
Zeuss, Inc. is an enterprise software company headquartered in San Francisco, California. It specializes in an information management platform that leverages a patent-pending technology known as the Zeuss Data Intelligence Engine (ZDIE). This platform enables users to intuitively discover actionable insights from both structured and unstructured data. By employing advanced semantic and natural language processing techniques, Zeuss facilitates the recovery, analysis, and dissemination of electronic messages from current and former employees. The company aims to enhance knowledge management and intelligence solutions, thereby improving productivity and maintaining continuity for organizations in both the private and public sectors.

Weather Analytics

Convertible Note in 2013
Weather Analytics specializes in providing precision climate data and weather intelligence, integrating dynamic weather and sensor station information. The company aggregates and formats weather data to deliver it in a user-friendly manner, enabling clients to concentrate on addressing their business challenges rather than spending time on data collection and cleansing. By streamlining access to high-quality weather information, Weather Analytics empowers organizations to utilize this data effectively for decision-making and operational efficiency.

ReelGenie

Seed Round in 2013
ReelGenie, LLC is a company based in Silver Spring, Maryland, that offers an online platform for creating videos from customers' photos and digital media. Founded in 2012, ReelGenie allows users to transform personal experiences, such as vacations and weddings, into dynamic films by combining multimedia elements like photos, video clips, narration, music, and text. The platform provides options for users to either generate an automatic video or utilize editing features for a more customized product. Videos can be shared online, downloaded, or purchased as DVDs. By facilitating video storytelling, ReelGenie enhances brand engagement and creates opportunities for revenue generation.

SocialToaster

Convertible Note in 2013
SocialToaster, Inc. operates an enterprise-level fan engagement platform that leverages social media to amplify a brand's messaging. Founded in 2009 and based in Baltimore, Maryland, the company provides a custom web-based application that enables users to identify, recruit, and activate their most passionate supporters. This platform allows brands to engage their fans authentically and reach new audiences through third-party endorsements. By empowering super fans to easily share content across their social networks, SocialToaster enhances fan advocacy and loyalty. The platform includes tools for managing social media campaigns, marketing emails, contests, and gamification, all supported by real-time reporting to assess campaign effectiveness and highlight top influencers.

RedOwl

Grant in 2013
RedOwl is a company that specializes in providing proactive risk oversight software solutions focused on compliance, insider threats, and investigations. Founded in 2011 and headquartered in Baltimore, Maryland, RedOwl offers a SaaS-based security analytics platform that leverages cloud computing technology to analyze large volumes of communications and transactional data. This sophisticated analytics software enhances situational awareness by identifying potential risks such as espionage, intellectual property theft, and compromised users. By assessing behavioral changes and detecting relevant anomalies in corporate digital activities, RedOwl aims to reduce organizational risk and liability.

Maxtena

Seed Round in 2013
Founded in 2006, Maxtena specializes in designing and manufacturing advanced satellite antennas and wireless communication systems. The company offers a range of antennas for various applications including Global Navigation Satellite Systems (GNSS), SATCOM, and 4G LTE. Serving industries such as automotive, mobile computing, healthcare, and power management, Maxtena empowers customers with precision and autonomous multi-frequency solutions.

Adlyfe

Convertible Note in 2013
Adlyfe is a biotechnology company established in 2003, dedicated to the development of innovative diagnostic products for neurodegenerative diseases linked to amyloidogenesis. This process involves the misfolding of normally soluble proteins, leading to their aggregation and deposition in brain tissue, which ultimately results in the loss of neural cells and brain tissue. Adlyfe specializes in creating biomarkers and diagnostic tests aimed at detecting human neurodegenerative conditions, including sporadic and variant Creutzfeldt-Jakob disease, as well as transmissible spongiform encephalopathy (TSE) diseases in animals. By focusing on these critical health issues, Adlyfe aims to enhance patient outcomes through timely and accurate detection of these debilitating diseases.

Nuo Therapeutics

Private Equity Round in 2013
Nuo Therapeutics develops, markets, and licenses regenerative biological therapies for wound care, inflammation, and angiogenesis. Its flagship product is the AutoloGel System, an FDA-cleared device that produces platelet-rich plasma gel from a patient's own blood.

3CLogic

Convertible Note in 2013
3CLogic is a cloud-based contact center solutions provider that enables organizations to manage internal and external communications and customer engagements through interactive voice response and multi-channel automatic call distribution for call routing and a predictive dialer. The platform supports inbound, outbound, and blended interactions across industries such as finance, real estate, insurance, e-commerce, healthcare, and education. It integrates with cloud-based customer relationship management and data platforms to extend CRM capabilities, enabling scalable features like self-service experiences, live and virtual agent interactions, and conversational analytics. 3CLogic offers flexible deployment options, from simple connectors between legacy telephony and cloud CRM to hybrid or full cloud deployments, designed to improve operational efficiency and customer service management through automation, consolidated reporting, and analytics.

BrainScope Company

Series A in 2012
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.

Theranostics Health

Venture Round in 2012
Theranostics Health, Inc. is a Maryland-based company specializing in protein-based biomarker discovery and translational research services aimed at enhancing drug development. Established in 2006, it offers a range of proteomic services, including proteomic profiling and laser capture microdissection, which are essential for companies engaged in developing molecular targeted therapies. The company is known for its advanced technologies, such as the Reverse Phase Protein Array, which allows for sensitive and quantitative analysis of cellular proteins from limited sample sizes. Additionally, Theranostics Health has developed TheraLin, a non-formalin-based tissue fixative that preserves the morphology and integrity of proteins in tissue samples. The company's services are utilized in various stages of drug development, from preclinical studies to clinical trials, enabling personalized cancer therapies tailored to individual patients' tumor profiles. As of May 2016, Theranostics Health operates as a subsidiary of Avant Diagnostics, Inc.

Maxtena

Seed Round in 2012
Founded in 2006, Maxtena specializes in designing and manufacturing advanced satellite antennas and wireless communication systems. The company offers a range of antennas for various applications including Global Navigation Satellite Systems (GNSS), SATCOM, and 4G LTE. Serving industries such as automotive, mobile computing, healthcare, and power management, Maxtena empowers customers with precision and autonomous multi-frequency solutions.

Zero Chroma

Venture Round in 2012
ZeroChroma LLC, founded in 2009 and headquartered in Sykesville, Maryland, specializes in designing and selling protective cases for mobile electronics, specifically for iPads and iPhones. The company markets its innovative products both online in the United States and internationally. ZeroChroma is recognized for its unique technology, which features a versatile kickstand that allows users to position their devices in various angles for optimal viewing in both portrait and landscape modes. Additionally, the Flux-Stand functions as a handle for ease of use while on the go and can be attached to multiple surfaces such as car dashboards and refrigerators, enhancing the overall functionality of mobile devices.

Zenoss

Series C in 2012
Zenoss develops IT operations management solutions, monitoring hybrid IT environments for service disruptions. Its SaaS platform, Zenoss Cloud, collects machine data to provide real-time visibility and predictive analytics, serving industries like federal, financial, and technology sectors.

20/20 Gene Systems

Seed Round in 2012
20/20 GeneSystems Inc. is a biotechnology company based in Rockville, Maryland, focused on developing and commercializing diagnostic tests for the early detection of cancer. The company offers several products, including PAULA’s Test, a blood test for lung cancer detection, and OneTest, which screens for multiple cancer types, such as lung, liver, and pancreatic cancers. Additionally, 20/20 provides BioCheck, a detection kit for screening suspicious powders, and Layered ImmunoHistoChemistry, which predicts the efficacy of targeted cancer therapies. The firm also offers CoronaCheck Tests, specializing in COVID-19 antibody testing. With a commitment to reducing cancer mortality, 20/20 GeneSystems employs advanced biomarker technologies and collaborates with various health agencies and organizations to enhance cancer diagnostics and promote personalized medicine.

PathSensors

Convertible Note in 2012
PathSensors, Inc. is a biotechnology and environmental testing company based in Baltimore, Maryland. Founded in 2009, it specializes in high-speed and high-sensitivity detection solutions for pathogens and biological threats, catering to both government and commercial sectors. The company offers several systems, including BioFlash-E, which combines biological aerosol sample collection with near real-time detection capabilities; Zephyr, designed for sensitive identification of biological threats from various surfaces and liquids; and PathSensors Navigator, which automates high-volume sample analysis. Their biosensors can identify a range of pathogens, including Salmonella, Bacillus anthracis, and Ricin toxin. PathSensors' technologies find applications in areas such as biosecurity, food safety, environmental monitoring, and public health. The company operates as a subsidiary of Smiths Detection Inc.

Akonni Biosystems

Series C in 2012
Akonni Biosystems, Inc. is a biotechnology company specializing in molecular diagnostics, focusing on the development and manufacture of integrated systems for clinical and life science research markets. Founded in 2003 and headquartered in Frederick, Maryland, the company offers a range of products, including the TruDiagnosis point-of-care testing platform, which allows healthcare professionals to analyze infectious diseases effectively. Its product lineup features TruTip kits for DNA and RNA extraction, TruArray tests for multiplexed molecular diagnostics from various clinical samples, and various MDx instrument platforms such as microarray readers and thermal cyclers. The company’s technologies are particularly relevant for diagnosing infectious diseases, pharmacogenomics, oncology, Alzheimer’s, and cardiovascular conditions, addressing complex health issues including multi-drug-resistant infections.

Instant Labs Medical Diagnostics Corp.

Convertible Note in 2012
InstantLabs, a molecular diagnostic device company, developed and markets the Hunter Real-Time-PCR® system, a fully-integrated, portable, and affordable real-time polymerase chain reaction (RT-PCR) platform for rapid, accurate pathogen detection. They focus on Molecular Diagnostic Equipment, Food Safety Testing Equipment, Food Verification Testing Equipment, Microbial Corrosion, Microbiologically Influenced Corrosion, Pathogen Testing, and On-Site labs.

Plasmonix

Debt Financing in 2012
Plasmonix is a biotechnology company founded in 2009 and located in Baltimore, Maryland. It specializes in Metal Enhanced Fluorescence (MEF) technology, which significantly improves the emission of light signals, allowing for the detection of molecular targets at concentrations as low as several hundred molecules. This advancement facilitates applications in life sciences and diagnostic assays. Additionally, Plasmonix develops a cell lysis device that employs microwave energy to break open bacterial and cellular contents, enabling the analysis of their molecular components and genetic profiles. Through its innovative technologies, Plasmonix aims to enhance detection capabilities in various scientific fields.

Bambeco

Venture Round in 2012
Bambeco, Inc. is a retailer specializing in sustainably sourced home furnishings and decor products, aimed at promoting eco-conscious living. Founded in 2008 and based in Baltimore, Maryland, the company offers a diverse range of items including furniture, rugs, pillows, wall hangings, and decorative accents. In addition to home decor, Bambeco provides kitchen and entertaining products such as dinnerware and barware, as well as bed and bath essentials like duvets, sheets, and spa accessories. The company also features outdoor products, including barbecue tools and garden supplies, as well as items for pets and office accessories. Bambeco’s commitment to sustainability is reflected in its use of recycled materials, allowing customers to create stylish and environmentally friendly living spaces. The company primarily serves its clientele through online sales.

410 Labs

Series A in 2011
410 Labs, Inc. is a technology company based in Baltimore, Maryland, founded in 2010. The company specializes in developing applications that enhance communication and information access. Its flagship product, Chuck, is an iPhone application designed for managing email more effectively. In addition to Chuck, 410 Labs has created other tools such as Replyz, which facilitates interactions with helpful individuals, and Shortmail, which aims to simplify and improve the email experience. The company focuses on utilizing message cleanup technologies that allow users to manage their communications more efficiently, including the ability to delete large volumes of messages simultaneously. Through its innovative applications, 410 Labs seeks to transform how people communicate and access information.

JobOn

Seed Round in 2011
JobOn is a recruitment technology company that streamlines hourly staff hiring for businesses in the retail, restaurant, and hospitality sectors. By prioritizing video interviews over traditional paper applications, JobOn enables employers to reduce time spent on hiring by 75%, lower recruitment costs, and make more informed decisions about candidates. This approach improves efficiency by allowing managers to focus on the most promising applicants first, rather than being distracted by walk-in applicants or multiple applications.

Fidelis Cybersecurity

Series B in 2008
Fidelis Cybersecurity, Inc. specializes in providing visibility and control products and services designed to detect, investigate, and prevent sophisticated cyber-attacks for both commercial enterprises and government clients globally. The company's key offerings include the Fidelis XPS platform, which helps organizations identify and mitigate advanced threats throughout the attack lifecycle, and the Resolution1 Endpoint solution, which enhances incident response and enables security teams to manage security events effectively. Additionally, Fidelis Endpoint 6.1 provides real-time insights into security incidents, facilitating quicker investigations. The company also offers deployment services, product training, and consulting services such as incident response and security assessments. Founded in 2002 and headquartered in Waltham, Massachusetts, with an office in Bethesda, Maryland, Fidelis Cybersecurity was formerly known as General Dynamics Fidelis Cybersecurity Solutions, Inc. and rebranded in May 2015.

A&G Pharmaceutical

Series A in 2005
A&G Pharmaceutical, Inc. is a theranostics company focused on discovering, developing, and commercializing personalized medicine products aimed at improving the screening, monitoring, and targeted treatment of cancer and other diseases. Founded in 2000 and headquartered in Columbia, Maryland, the company specializes in creating monoclonal antibodies targeting cancer-specific biomarkers. Its portfolio includes GP88, a growth factor associated with breast cancer, which is utilized in diagnostic test kits designed to enhance early detection and treatment of the disease. Additionally, A&G develops anti-GP88 monoclonal antibody therapeutics and customized antibodies for various cancers, including ovarian, pancreatic, prostate, and lung cancer. The company serves pharmaceutical and biotechnology firms, as well as federal laboratories, and generates revenue through its customized antibody service, supporting ongoing drug development efforts.

Alba Therapeutics

Series A in 2005
Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company based in Baltimore, Maryland, specializing in the discovery and development of therapeutics for autoimmune and inflammatory diseases. The company’s innovative approach revolves around modifying epithelial permeability through compounds that regulate tight junctions in cellular barriers, addressing conditions related to autoimmunity. Alba's research targets a variety of disorders, including celiac disease, asthma, chronic obstructive pulmonary disease (COPD), and acute lung injury, as well as other immune-mediated and inflammatory diseases. The company's focus extends to therapeutic areas such as type 1 diabetes, inflammatory bowel disease (IBD), mucosal vaccines, and drug delivery systems, aiming to improve treatment outcomes for patients suffering from diverse health challenges.

Innovative Biosensors

Series A in 2005
Innovative Biosensors' technology is built upon a foundation of a genetically engineered biosensor that allows for extremely rapid testing of analytes, providing high levels of sensitivity and specificity. The patented, self-contained biosensor system is capable of generating a sensitive and specific result with minimal amount of reagents in minutes, making it a cost-effective alternative to traditional laboratory testing. In addition, the biosensors can be engineered to detect one target or several targets of interest simultaneously and used to perform a wide variety of bioassays. Designed for real-time detection, minimally-skilled personnel can perform tests and analysis at the site of sampling using small, portable, space-saving instrumentation

BioSET

Series B in 2004
BioSET, Inc., founded in 2001 and based in Rockville, Maryland, specializes in the research and development of synthetic bioactive peptides aimed at enhancing bone and soft tissue repair. The company creates proprietary therapeutic peptides utilized as medical devices in orthobiologics applications. Its notable product, Amplex, is an implantable device that combines a peptide with a synthetic ceramic scaffold, designed for use in spinal fusion surgeries and other orthopedic procedures. Additionally, BioSET develops products for sports medicine and creates peptide signaling molecules along with various scaffold biomaterials for applications in trauma, fracture repair, and soft tissue treatments. As of February 2015, BioSET operates as a subsidiary of Ferring Pharmaceuticals Inc.

BioSET

Series A in 2002
BioSET, Inc., founded in 2001 and based in Rockville, Maryland, specializes in the research and development of synthetic bioactive peptides aimed at enhancing bone and soft tissue repair. The company creates proprietary therapeutic peptides utilized as medical devices in orthobiologics applications. Its notable product, Amplex, is an implantable device that combines a peptide with a synthetic ceramic scaffold, designed for use in spinal fusion surgeries and other orthopedic procedures. Additionally, BioSET develops products for sports medicine and creates peptide signaling molecules along with various scaffold biomaterials for applications in trauma, fracture repair, and soft tissue treatments. As of February 2015, BioSET operates as a subsidiary of Ferring Pharmaceuticals Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.